The Latest Research on GLP-1s and Mental Health: No Increased Risk of Suicide In January 2024, researchers at Case Western Reserve University released the results of a study that looked at medical records of over 1.5 million people with type 2 diabetes or obesity
Quick Answer: Tirzepatide may cause tiredness in some patients, though fatigue is not listed among the most common side effects in clinical trials, with indirect mechanisms like reduced caloric intake and gastrointestinal effects potentially contributing to this symptom
Our response is that would not be clinically appropriate, said Thoms, noting patients needed to have face-to-face consultations every four weeks to ensure the medication remained right for them, review goals and receive wraparound support
This is a critical difference from nausea-driven appetite loss, which feels unpleasant
Inflammatory markers decreased
Participation in the Program requires a valid patient HIPAA authorization